Open Targets Platform: new developments and updates two years on

被引:301
作者
Carvalho-Silva, Denise [1 ,2 ]
Pierleoni, Andrea [1 ,2 ]
Pignatelli, Miguel [1 ,2 ]
Ong, ChuangKee [1 ,2 ]
Fumis, Luca [1 ,2 ]
Karamanis, Nikiforos [1 ,2 ]
Carmona, Miguel [1 ,2 ]
Faulconbridge, Adam [1 ,2 ]
Hercules, Andrew [1 ,2 ]
McAuley, Elaine [1 ,2 ]
Miranda, Alfredo [1 ,2 ]
Peat, Gareth [1 ,2 ]
Spitzer, Michaela [1 ,2 ]
Barrett, Jeffrey [2 ,3 ]
Hulcoop, David G. [2 ,4 ]
Papa, Eliseo [2 ,5 ]
Koscielny, Gautier [2 ,4 ]
Dunham, Ian [1 ,2 ]
机构
[1] EBI, EMBL, Wellcome Genome Campus, Hinxton CB10 1SD, Cambs, England
[2] Open Targets, Wellcome Genome Campus, Hinxton CB10 1SD, Cambs, England
[3] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England
[4] Med Res Ctr, GSK, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England
[5] Biogen, Cambridge, MA 02142 USA
关键词
GENOME-WIDE ASSOCIATION; CANCER; INFORMATION; HALLMARKS; DATABASE; ATLAS;
D O I
10.1093/nar/gky1133
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease associations for drug target identification. The associations are displayed in an intuitive user interface (https://www.targetvalidation.org), and are available through a REST-API (https://api.opentargets.io/v3/platform/docs/swagger-ui) and a bulk download (https://www.targetvalidation.org/downloads/data). In addition to target-disease associations, we also aggregate and display data at the target and disease levels to aid target prioritisation. Since our first publication two years ago, we have made eight releases, added new data sources for target-disease associations, started including causal genetic variants from non genome-wide targeted arrays, added new target and disease annotations, launched new visualisations and improved existing ones and released a new web tool for batch search of up to 200 targets. We have a new URL for the Open Targets Platform REST-API, new REST endpoints and also removed the need for authorisation for API fair use. Here, we present the latest developments of the Open Targets Platform, expanding the evidence and target-disease associations with new and improved data sources, refining data quality, enhancing website usability, and increasing our user base with our training workshops, user support, social media and bioinformatics forum engagement.
引用
收藏
页码:D1056 / D1065
页数:10
相关论文
共 40 条
  • [11] Pharos: Collating protein information to shed light on the druggable genome
    Dac-Trung Nguyen
    Mathias, Stephen
    Bologa, Cristian
    Brunak, Soren
    Fernandez, Nicolas
    Gaulton, Anna
    Hersey, Anne
    Holmes, Jayme
    Jensen, Lars Juhl
    Karlsson, Anneli
    Liu, Guixia
    Ma'ayan, Avi
    Mandava, Geetha
    Mani, Subramani
    Mehta, Saurabh
    Overington, John
    Patel, Juhee
    Rouillard, Andrew D.
    Schurer, Stephan
    Sheils, Timothy
    Simeonov, Anton
    Sklar, Larry A.
    Southall, Noel
    Ursu, Oleg
    Vidovic, Dusica
    Waller, Anna
    Yang, Jeremy
    Jadhav, Ajit
    Oprea, Tudor I.
    Guha, Rajarshi
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) : D995 - D1002
  • [12] Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data
    Denny, Joshua C.
    Bastarache, Lisa
    Ritchie, Marylyn D.
    Carroll, Robert J.
    Zink, Raquel
    Mosley, Jonathan D.
    Field, Julie R.
    Pulley, Jill M.
    Ramirez, Andrea H.
    Bowton, Erica
    Basford, Melissa A.
    Carrell, David S.
    Peissig, Peggy L.
    Kho, Abel N.
    Pacheco, Jennifer A.
    Rasmussen, Luke V.
    Crosslin, David R.
    Crane, Paul K.
    Pathak, Jyotishman
    Bielinski, Suzette J.
    Pendergrass, Sarah A.
    Xu, Hua
    Hindorff, Lucia A.
    Li, Rongling
    Manolio, Teri A.
    Chute, Christopher G.
    Chisholm, Rex L.
    Larson, Eric B.
    Jarvik, Gail P.
    Brilliant, Murray H.
    McCarty, Catherine A.
    Kullo, Iftikhar J.
    Haines, Jonathan L.
    Crawford, Dana C.
    Masys, Daniel R.
    Roden, Dan M.
    [J]. NATURE BIOTECHNOLOGY, 2013, 31 (12) : 1102 - +
  • [13] COSMIC: somatic cancer genetics at high-resolution
    Forbes, Simon A.
    Beare, David
    Boutselakis, Harry
    Bamford, Sally
    Bindal, Nidhi
    Tate, John
    Cole, Charlotte G.
    Ward, Sari
    Dawson, Elisabeth
    Ponting, Laura
    Stefancsik, Raymund
    Harsha, Bhavana
    Kok, Chai Yin
    Jia, Mingming
    Jubb, Harry
    Sondka, Zbyslaw
    Thompson, Sam
    De, Tisham
    Campbell, Peter J.
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) : D777 - D783
  • [14] A census of human cancer genes
    Futreal, PA
    Coin, L
    Marshall, M
    Down, T
    Hubbard, T
    Wooster, R
    Rahman, N
    Stratton, MR
    [J]. NATURE REVIEWS CANCER, 2004, 4 (03) : 177 - 183
  • [15] The ChEMBL database in 2017
    Gaulton, Anna
    Hersey, Anne
    Nowotka, Michal
    Bento, A. Patricia
    Chambers, Jon
    Mendez, David
    Mutowo, Prudence
    Atkinson, Francis
    Bellis, Louisa J.
    Cibrian-Uhalte, Elena
    Davies, Mark
    Dedman, Nathan
    Karlsson, Anneli
    Magarinos, Maria Paula
    Overington, John P.
    Papadatos, George
    Smit, Ines
    Leach, Andrew R.
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) : D945 - D954
  • [16] The hallmarks of cancer
    Hanahan, D
    Weinberg, RA
    [J]. CELL, 2000, 100 (01) : 57 - 70
  • [17] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674
  • [18] Honnibal Matthew, 2015, P 2015 C EMP METH NA, P1373, DOI [DOI 10.18653/V1/D15-1162, 10.18653/v1/D15-1162]
  • [19] Indyk P., 1997, P 29 ANN ACM S THEOR, P618, DOI DOI 10.1145/258533.258656
  • [20] Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich
    Iorio, Francesco
    Garcia-Alonso, Luz
    Brammeld, Jonathan S.
    Martincorena, Inigo
    Wille, David R.
    McDermott, Ultan
    Saez-Rodriguez, Julio
    [J]. SCIENTIFIC REPORTS, 2018, 8